Caspase inhibition increases embryonic striatal graft survival

Experimental Neurology

Volumn 164, Issue 1, 2000, Pages 112-120

  Mundt Petersen, Ulrika ^a   Petersén, Åsa ^a   Emgård, Mia ^a   Dunnett, Stephen B ^b   Brundin, Patrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Embryonic; Huntington's disease; Stereology; Striatal; Survival; Transplantation

Indexed keywords

CASPASE INHIBITOR; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOCHEMISTRY; DRUG EFFECT; ENZYME INHIBITION; GRAFT SURVIVAL; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOLOGY; SURVIVAL TIME;

EID: 0033943449     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7407     Document Type: Article

References (41)

1. Barker R. A., Fricker R. A., Abrous D. N., Fawcett J., Dunnett S. B. A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant. 4:1995;173-200.
2. Batchelor P. E., Liberatore G. T., Wong J. Y. F., Porrit M. J., Frerichs F., Donnan G. A., Howells D. W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19:1999;1708-1716.
3. Bayer S. A. Neurogenesis in the rat neostriatum. Int. J. Dev. Neurosci. 2:1984;163-175.
4. Brundin P., Karlsson J., Emgård M., Kaminski G. S., Hansson O., Petersén Å., Castilho R. F. Improving the survival of grafted dopaminergic neurons: A review over current approaches. Cell Transplant. 9:1999;179-195.
5. Chamak B., Morandi V., Mallat M. Brain macrophages stimulate neurite growth and regeneration by secreting thrombospondin. J. Neurosci. Res. 38:1994;221-233.
6. DiFiglia M., Schiff L., Deckel A. W. Neuronal organization of fetal striatal grafts in kainate- and sham-lesioned rat caudate nucleus: Light- and electron-microscopic observations. J. Neurosci. 8:1988;1112-1130.
7. Duan W. M., Widner H., Cameron R. M., Brundin P. Quinolinic acid-induced inflammation in the striatum does not impair the survival of neural allografts in rat. Eur. J. Neurosci. 10:1998;2595-2606.
8. Emgård M., Karlsson J., Hansson O., Brundin P. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Exp. Neurol. 160:1999;279-288.
9. Fawcett J. W., Barker R. A., Dunnett S. B. Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp. Brain Res. 106:1995;275-282.
10. Fricker R. A., Torres E. M., Hume S. P., Myers R., Opacka-Juffrey J., Ashworth S., Brooks D. J., Dunnett S. B. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience. 79:1997;711-721.
11. Gundersen H. J. G., Bagger P., Bendsten T. F., Evans S. M., Korbu L., Marcussen N., Møller A., Nielsen K., Nyengard J. R., Pakkenberg B., Sørensen F. B., Vesterby A., West M. J. The new stereological tools: Dissector, fractionator, nucleator and point-sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:1988;857-881.
12. Hedreen J. C., Bacon S. J., Price D. L. A modified histochemical technique to visualize acetylcholinesterase-containing axons. J. Histochem. Cytochem. 33:1985;134-140.
13. Isacson O., Dunnett S. B., Björklund A. Graft-induced behavioral recovery in an animal model of Huntington's disease. Proc. Natl. Acad. Sci. USA. 83:1986;2728-2732.
14. Kendall A. L., Rayment F. D., Torres E. M., Baker H. F., Ridley R. M., Dunnett S. B. Functional integration of striatal allografts in a primate model of Huntington's disease. Nature Med. 4:1998;727-729.
15. Labandeira-Garcia J. L., Wictorin K., Cunningham E. T. Jr., Björklund A. Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience. 42:1991;407-426.
16. Loddick S. A., MacKenzie A., Rothwell N. J. An ICE inhibitor, Z-VAD-DCB attenuates ischaemic brain damage in the rat. NeuroReport. 7:1996;1465-1468.
17. Mahalik T. J., Hahn W. E., Clayton G. H., Owenst G. P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129:1994;27-36.
18. Marchand R., Lajoie L. Histogenesis of the striatopallidal system in the rat: Neurogenesis of its neurons. Neuroscience. 17:1986;573-590.
19. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Prog. Neurobiol. 54:1998;99-125.
20. Mundt-Petersen U., Karlsson J., Kaminski G. S., Brundin P. Pretreatment with MK-801 or the lazaroid U-83836E does not enhance striatal graft survival. Cell Transplant. 9:1999;73-78.
21. Nakao N., Odin P., Brundin P. Selective sub-dissection of the striatal primordium for cultures affects the yield of DARPP-32-containing neurones. NeuroReport. 5:1994;1081-1084.
22. Nakao N., Grasbon-Frodl E. M., Widner H., Brundin P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw-reaching in an animal model of Huntington's disease. Neuroscience. 74:1996;959-970.
23. Nakao N., Brundin P. Effects of a-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinic or 3-nitropropionic acid. Neuroscience. 76:1997;747-761.
24. Oorschot D. E. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: A stereological study using the Cavalieri and optical disector methods. J. Comp. Neurol. 366:1996;580-599.
25. Palfi S., Conde F., Riche D., Brouillet E., Dautry C., Mittoux V., Chibois A., Peschanski M., Hantraye P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington's disease. Nature Med. 4:1998;963-966.
26. Petersén Å., Castillho R. F., Hansson O., Wieloch T., Brundin P. Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons. Brain Res. 857:2000;20-29.
27. Petersén Å., Emgård M., Brundin P. Impact of a preceding striatal excitotoxic lesion and treatment with ciliary neurotrophic factor on striatal graft survival. Brain Res. Bull. 50:1999;275-281.
28. Porter A. G., Ng P., Jänicke R. U. Death substrates come alive. Bioessays. 19:1997;501-507.
29. Salès N., Condé F., Bizat N., Adjou K., Brouillet E., Hantraye P. Fluoro-Jade: A fluorochrome for neuronal degeneration but also for glial cells. Soc. Neurosci. Abstr. 25:1999;3.
30. Schierle G. S, Hansson O., Leist M., Nicotera P, Widner H., Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nature Med. 5:1999;97-100.
31. Schmued L., Albertson C., Slikker W. J. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751:1997;37-46.
32. Schultz J. B., Weller M., Moskowitz M. A. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neurol. 34:1999;421-429.
33. Sinclair R. S., Fawcett J. W., Dunnett S. B. Dopamine cells in nigral grafts differentiate prior to implantation. Eur. J. Neurosci. 11:1999;4341-4348.
34. Specht L. A., Pickel V. M., Joh T. H., Reis D. J. Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat bran. I. Early ontogeny. J. Comp. Neurol. 199:1981;233-253.
35. Stoll G., Jander S., Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56:1998;149-171.
36. Thornberry N. A., Lazebnik Y. Caspases: Enemies within. Science. 281:1998;1312-1316.
37. Villa P., Kaufmann S. H., Earnshaw W. C. Caspases and caspase inhibitors. Trends Biochem. Sci. 22:1997;388-393.
38. Watts C., Caldwell M. A., Dunnett S. B. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplant. 7:1998;573-583.
39. Watts C., Dunnett S. B. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: Implications for timing of surgical intervention. J. Neurosurg. 89:1998;267-274.
40. Watts C., Dunnett S. B. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplant. 9:1999;223-234.
41. Zawada W. M., Zastrow D. J., Clarkson E. D., Adams F. S., Bell K. P., Freed C. R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 789:1998;96-103.